Thursday, 17 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14422
Articles
Company
Deals
CIIE: Bo’ao Lecheng Zone Announces Partnerships with Multinationals
February 1, 2025
Company
Cytiva Announces RMB 60M Investment for China Science Innovation Center at CIIE
February 1, 2025
Company
Drug
Innovent Biologics’ Tafolecimab Shows Strong LDL-C Reduction in Phase III Study
February 1, 2025
Company
Drug
Ascentage Pharma Presents APG-1387 Phase I Study Results at AASLD
February 1, 2025
Company
Deals
Allergan Aesthetics Partners with Sinopharm at CIIE for Aesthetic Medicine
February 1, 2025
Company
Deals
Honeywell Partners with Anruite for Smart Manufacturing in China
February 1, 2025
Company
Deals
Boehringer Ingelheim Launches Rehabilitation Center in Chengdu at CIIE
February 1, 2025
Company
Deals
Fosun Pharma Partners with Soong Ching Ling Foundation for Women and Children’s Health
February 1, 2025
Company
Deals
Jumpcan Partners with Newsoara for PDE4 and Protease Inhibitors in China
February 1, 2025
Company
Novo Nordisk to Invest RMB 400M in Shanghai at CIIE
February 1, 2025
Company
Drug
Jiangsu Yahong Initiates Phase III Study for Hexvix in Bladder Cancer Detection
February 1, 2025
Company
Drug
Betta Pharmaceuticals’ BPI-452080 Accepted for Review by NMPA
February 1, 2025
1
2
…
1,101
1,102
1,103
1,104
1,105
…
1,201
1,202
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
